For example, CMP can reduce tumor growth in vivo by potentially inducing apoptosis in tumor cells by interfering with claudin-4 (17), while the expression of LAT1 has been reported to be modified using forskolin (69), thus potentially altering the activity of the bidirectional transport system of amino acids (54). The gene discussed is CLDN4; the disease is neoplasm.